Study of retinoic acid polymorphism

Journal of Pharmaceutical Sciences

Volumn 95, Issue 10, 2006, Pages 2207-2221

  Caviglioli, Gabriele ^a   Pani, Marcella ^a   Gatti, Paolo ^b   Parodi, Brunella ^a   Cafaggi, Sergio ^a   Bignardi, Gaetano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NERVIANO MEDICAL SCIENCES   (Italy)

Author keywords

Calorimetry (DSC); Infrared spectroscopy; Kinetics; Polymorphism; Raman spectroscopy; Solid state; Solubility; Stability; X ray powder diffractometry

Indexed keywords

RETINOIC ACID;

ARTICLE; CALORIMETRY; CONFORMATIONAL TRANSITION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; KINETICS; RAMAN SPECTROMETRY; SOLID STATE; SOLUBILITY; THERMAL ANALYSIS; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

EID: 33749986489     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20699     Document Type: Article

References (44)

1. Sanz MA, Tallman MS, Lo-Coco F. 2005. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood 105:3019.
2. Niles RM. 2004. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res Fundamen Mol Mech Mutagenesis 555:97-105.
3. Geller RB, Dix SP. 1999. Oral chemotherapy agents in the treatment of leukaemia. Drugs 58:109.
4. Stam CH, MacGillavry CH. 1963. The crystal structure of the triclinic modification of vitamin A acid. Acta Crystallogr 16:62.
5. Stam CH. 1972. Crystal structure of a monoclinic modification and the refinement of a triclinic modification of vitamin A acid (retinoic acid), C20H28O2. Acta Crystallogr Sect B Struct Crystallogr Crystal Chemistry 28:2936.
6. Rockley NL, Halley BA, Rockley MG, Nelson EC. 1983. Infrared spectroscopy of retinoids. Anal Biochem 133:314.
7. Szuts EZ, Harosi FI. 1991. Solubility of retinoids in water. Arch Biochem Biophys 287:297.
8. Harbison GS, Mulder PPJ, Pardoen H, Lugtenburg J, Herzfeld J, Griffin RG. 1985. High-resolution carbon-13 NMR of retinal derivatives in the solid state. J Am Chem Soc 107:4809.
9. Tan X, Meltzer N, Lindenbaum S. 1992. Solid-state stability studies of 13-cis-retinoic acid and all-trans-retinoic acid using microcalorimetry and HPLC analysis. Pharm Res 9:1203.
10. Andrew ER, Peplinska B. 1998. Molecular motion in solid all-trans retinoic acid (vitamin A acid) by proton NMR. Solid State Nucl Magn Reson 13:39.
11. Berbenni V, Marini A, Bruni G, Cardini A. 2001. Thermoanalytical and spectroscopic characterization of solid-state retinoic acid. Int J Pharm 221:123.
12. Han C-H, Wiedmann TS. 1998. Spectral properties and ion dissociation behavior of retinoids I. Aqueous solutions. Int J Pharm 172:241-253.
13. Pullman B, Langlet J, Berthod H. 1969. On the S-cis-S-trans isomerism of the cyclohexene ring with respect to the polyene chain in retinals, carotenoids, vitamins A and related compounds. J Theor Biol 23:492.
14. Langlet J, Pullman B, Berthod H. 1970. Quantum study of the s-cis-s-trans isomerization of the cyclohexene ring with respect to the polyene side chain in retinal and β-ionylidenecrotonic acid. J Mol Struct 6:139-144.
15. Yvon K, Jeitschko W, Parthe E. 1977. LAZY PULVERIX, a computer program for calculating X-ray and neutron diffraction powder patterns. J Appl Crystallogr 10:73-74.
16. Caviglioli G, Parodi B, Cafaggi S, Bignardi G, Romussi G. 1994. Stability-indicating HPLC assay for retinoic acid in hard gelatin capsules containing lactose and as bulk drug substance. Drug Dev Ind Pharm 20:2395-2408.
17. Hancock JD, Sharp JH. 1972. Method of comparing solid-state kinetic data and its application to the decomposition of kaolinite, brucite, and barium carbonate. J Am Ceramic Soc 55:74.
18. Kissinger HE. 1957. Reaction kinetics in differential thermal analysis. Anal Chem 29:1702.
19. Gavezzotti A. 2003. OPiX, A computer program package for the calculation of intermolecular interactions and crystal energies. University of Milano.
20. Filippini G, Gavezzotti A. 1993. Empirical intermolecular potentials for organic-trystals-The 6-Exp approximation revisited. Acta Crystallogr Sect B-Struct Commun 49:868-880.
21. Gavezzotti A, Filippini G. 1994. Geometry of the intermolecular X-H...Y (X, Y = N, O) hydrogen bond and the calibration of empirical hydrogen-bond potentials. J Phys Chem 98:4831.
22. Allen FH, Davies JE, Galloy JJ, Johnson O, Kennard O, Macrae CF, Mitchell EM, Mitchell GF, Smith JM, Watson DG. 1991. The development of versions 3 and 4 of the Cambridge Structural Database System. J Chem Inf Comput Sci 31:187-204.
23. Bar I, Bernstein J. 1985. Conformational polymorphism. VI: The crystal and molecular structures of form II, form III, and form V of 4-amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine). J Pharm Sci 74:255.
24. Hirayama F, Wang Z, Uekama K. 1994. Effect of 2-hydroxypropyl-β- cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state. Pharm Res 11:1766.
25. Griesser UJ, Burger A, Mereiter K. 1997. The Polymorphic Drug Substances of the European Pharmacopoeia. Part 9. Physicochemical Properties and Crystal Structure of Acetazolamide Crystal Forms. J Pharm Sci 86:352.
26. Kimura K, Hirayama F, Uekama K. 1999. Characterization of tolbutamide polymorphs (Burger's Forms II and IV) and polymorphic transition behavior. J Pharm Sci 88:385.
27. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. Mikrochimica Acta 2:259.
28. Pouchert CJ. 1981. The Aldrich Library of Infrared Spectra. 3rd Ed. 1873. Milwaukee: Aldrich Chemical Co., p 1873.
29. Caviglioli G, Parodi B, Cafaggi S, Bignardi G, Caviglia D, Palmero S, Scarabelli L, Carnasciali M. 2004. European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain, May 10-12, p. 26.
30. Brittain HG, Grant DJW. 1999. Effects of polymorphism and solid-state solvation on solubility and dissolution rate. Drugs Pharm Sci 95(Polymorphism in Pharmaceutical Solids):279-330.
31. Martinez-Oharriz MC, Martin C, Goni MM, Rodriguez-Espinosa C, Tros-De-Ilarduya-Apaolaza MC, Sanchez M. 1994. Polymorphism of Diflunisal-Isolation and Solid-State Characteristics of a New Crystal Form. J Pharm Sci 83:174-177.
32. Ravin LJ, Shami EG, Rattie E. 1970. Physical-chemical evaluation of 3-(3-hydroxy-3-methylbutylamino)-5-methyl-as, triazino. J Pharm Sci 59:1290-1295.
33. Chan H-K, Grant DJW. 1989. Influence of compaction on the intrinsic dissolution rate of modified acetaminophen and adipic acid crystals. Int J Pharm 57:117-124.
34. Muster TH, Prestidge CA. 2002. Face specific surface properties of pharmaceutical crystals. J Pharm Sci 91:1432-1444.
35. Gibaldi M, Feldman S, Weiner ND. 1970. Hydrodynamic and diffusional considerations in assessing the effects of surface active agents on the dissolution rate of drugs. Chem Pharm Bull 18:715-723.
36. Buckton G. 1993. Assessment of the Wettability of Pharmaceutical Powders. J Adhes Sci Technol 7:205-219.
37. Buckton G, Newton JM. 1986. Assessment of the wettability of powders by use of compressed powder discs. Powder Technol 46:201-208.
38. Bauer J, Spanton S, Henry R, Quick J, Dziki W, Porter W, Morris J. 2001. Ritonavir: An extraordinary example of conformational polymorphism. Pharm Res 18:859-866.
39. Chen XM, Morris KR, Griesser UJ, Byrn SR, Stowell JG. 2002. Reactivity differences of indomethacin solid forms with ammonia gas. J Am Chem Soc 124:15012-15019.
40. Caviglioli G, Parodi B, Posocco V, Cafaggi S, Bignardi G. 2000. Stability study of hard gelatin capsules containing retinoic acid. Drug Dev Ind Pharm 26:995-1001.
41. Oyler AR, Motto MG, Naldi RE, Facchine KL, Hamburg PF, Burinsky DJ, Dunphy R, Cotter ML. 1989. Characterization of autoxidation products of retinoic acid. Tetrahedron 45:7679-7694.
42. Caviglioli G, Cafaggi S, Parodi B, Russo E, Bignardi G. 1994. Stability indicating TLC for retinoic acid in hard gelatine capsules containing lactose and as bulk drug substance. Acta Technologiae et Legis Medicamenti 5:69-85.
43. Byrn SR, Xu W, Newman AW. 2001. Chemical reactivity in solid-state pharmaceuticals: Formulation implications. Adv Drug Deliv Rev 48:115-136.
44. Zhang GGZ, Chonghui G, Zell MT, Burkhardt RT, Munson EJ, Grant DJW. 2002. Crystallization and transitions of sulfamerazine polymorphs. J Pharm Sci 91:1089-1100.